Authors: Montgomery, SA Loft, H Sanchez, C Reines, EH Papp, M

Citation: Sa. Montgomery et al., Letter to the editor, PHARM TOX, 89(4), 2001, pp. 154-155

Authors: Montgomery, SA Loft, H Sanchez, C Reines, EH Papp, M

Citation: Sa. Montgomery et al., Escitalopram (S-Enantiomer of citalopram): Clinical efficacy and onset of action predicted from a rat model, PHARM TOX, 88(5), 2001, pp. 282-286

Authors: Guelfi, JD Strub, N Loft, H

Citation: Jd. Guelfi et al., Efficacy of intravenous citalopram compared with oral citalopram for severe depression - Safety and efficacy data from a double-blind, double-dummy trial, J AFFECT D, 58(3), 2000, pp. 201-209

Authors: Thal, LJ Forrest, M Loft, H Mengel, H

Citation: Lj. Thal et al., Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer'sdisease, NEUROLOGY, 54(2), 2000, pp. 421-426

Authors: Kristensen, B Ejlertsen, B Groenvold, M Hein, S Loft, H Mouridsen, HT

Citation: B. Kristensen et al., Oral clodronate in breast cancer patients with bone metastases: a randomized study, J INTERN M, 246(1), 1999, pp. 67-74